(Q34560752)

3 August 2017

title

Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells (English)

1 reference

3 August 2017

0 references

Wenrui Duan

1

1 reference

3 August 2017

Li Gao

2

1 reference

3 August 2017

Xin Wu

3

1 reference

3 August 2017

Yang Zhang

4

1 reference

3 August 2017

Gregory A Otterson

5

1 reference

3 August 2017

Miguel A Villalona-Calero

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

21 July 2006

1 reference

Experimental Cell Research

3 August 2017

published in

1 reference

3 August 2017

volume

312

1 reference

3 August 2017

issue

17

1 reference

3 August 2017

page(s)

3370-3378

1 reference

Wild-type p53 activates transcription in vitro

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

WAF1, a potential mediator of p53 tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

p21 is a universal inhibitor of cyclin kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

The IARC TP53 database: new online mutation analysis and recommendations to users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Identification of p53 as a sequence-specific DNA-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Radiation-induced cell cycle arrest compromised by p21 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Loss of p53 and centrosome hyperamplification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Tumor spectrum analysis in p53-mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Amplification of a gene encoding a p53-associated protein in human sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Mdm2 promotes the rapid degradation of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Regulation of p53 stability by Mdm2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

mdm2 expression is induced by wild type p53 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

The mdm-2 gene is induced in response to UV light in a p53-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

RT-PCR heteroduplex analysis permits differentiation of transgene and host gene expression in a transgenic animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Induction of Mdm2 and enhancement of cell survival by bFGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Regulation of p53 downstream genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

A new human gene hNTKL-BP1 interacts with hPirh2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

The ubiquitin ligase COP1 is a critical negative regulator of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

JNK targets p53 ubiquitination and degradation in nonstressed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

A comparison of the biological activities of wild-type and mutant p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2006.07.005

1 reference

3 August 2017

1 reference